問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taipei Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2021-01-04 - 2026-04-30
Condition/Disease
This is a Phase 3, open-label, trial designed to evaluate CG0070 in patients with high-grade CIS of the bladder unresponsive to Bacillus Calmette-Guerin (BCG).
Test Drug
CG0070 DDM
Participate Sites4Sites
Recruiting4Sites
2025-09-01 - 2032-12-31
Participate Sites6Sites
Recruiting6Sites
2023-06-16 - 2026-07-31
moderate-to-severe systemic lupus erythematosus (SLE)
tablet
Participate Sites11Sites
Not yet recruiting1Sites
Recruiting10Sites
2021-09-01 - 2025-03-31
Participate Sites5Sites
Recruiting5Sites
2022-03-01 - 2025-12-31
Participate Sites7Sites
Recruiting7Sites
2025-06-15 - 2027-04-17
2023-12-26 - 2026-05-14
xxxxxx
Not yet recruiting5Sites
Recruiting1Sites
2022-04-01 - 2029-10-31
2021-09-01 - 2025-04-30
2025-05-01 - 2027-07-30
Participate Sites2Sites
Recruiting2Sites
全部
